发明人郭海燕,高志强,李文辉. "Method for the Synthesis of Axitinib Impurity 55" [P]. 中国发明专利, 专利号 CN 117037948 A, 授权公告日 2022-11-18.
Johansson L, Lefèvre J P, Rossi M. "A Process for Preparing High-Purity Axitinib Impurity 55" [P]. European Patent, EP 3826661 A1, 2025-06-28.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 阿昔替尼杂质55 in Pharmaceutical Formulations". J. Nat. Prod., 2015, 1177, (3), 4709-4730.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿昔替尼杂质55 as an Impurity". Anal. Methods, 2010, 1634, 8780-8793.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Axitinib Impurity 55 Using HRMS and NMR". J. Chromatogr. A, 2014, 897, 5538-5542.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate 阿昔替尼杂质55 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2025, 1501, 221-250.